The global medical specialty bags market is projected to grow from US$9.8 billion in 2024 to US$13.6 billion by 2031, registering a CAGR of 4.7%. This growth is driven by increasing chronic diseases, rising demand for home healthcare, and the prevalence of single-use bags due to infection control benefits. IV bags remain the leading product category, while polyethylene dominates the market by material due to its cost-effectiveness and durability, growing at a projected CAGR of 5.1%. North America leads the market, supported by a strong healthcare infrastructure and high demand for advanced medical solutions. Europe also sees robust demand fueled by medical innovations and a rise in chronic conditions.